The world’s first dynamic knee health monitoring brace for daily use—where protection meets medical-grade AI analytics.
We’re not just building a knee brace—we’re building the gold standard for wearable knee health for three billion people worldwide who suffer from knee pain, sports injuries, or post-rehab needs. Our CTA shortlist status for CES 2026 is just the start: we’re positioned to dominate billion global market (Statista, 2026) at the intersection of digital health, wearable tech, and orthopedic care.
Investor-Ready Moats
-
Patented Flexible Sensing Technology – Unlike generic braces that only protect, our proprietary sensors track knee angle, pressure distribution, and movement patterns in real time—with 94.81% accuracy (clinically validated by PEKING UNIVERSITY SHENZHEN HOSPITAL).
-
AI-Driven Risk & Recovery Analytics – Our algorithm predicts injury risk before it happens (critical for athletes) and optimizes post-op rehab timelines (proven to reduce recovery time by 30% in early user tests).
-
Dual Market Traction – We’ve secured early interest from HK PolyU's physical therapy clinics and pre-orders from numerous consumers.
-
Regulatory Momentum – Currently progressing through certification (target approval: Q4 2026) – a critical barrier to entry that keeps generic competitors out.
Our Market Size
1
Total Addressable Market
USD 11.6 Billion (2030) – Global digital health for musculoskeletal care (including wearable sensors, remote monitoring, and rehab platforms).
2
Serviceable Addressable Market
USD 3.5 Billion (2030, illustrative) – Estimated portion of that market in North America, Europe, and APAC specifically addressable by medical‑grade knee monitoring and rehab wearables (subset of global MSK digital health spend).
3
Serviceable Obtainable Market
USD 35 Million (3‑year target) – 1% of SAM, representing the revenue Mirror Caring aims to capture over the first 3 years with this funding round (via hospitals, rehab centers, sports medicine, and home‑rehab users).
Exit Strategy
We’ve built Mirror Caring with a clear path to return for our investors:
1. Strategic Acquisition (3-5 Years): Targeted by medical device giants (e.g., Johnson & Johnson, Stryker, Garmin) who are actively acquiring wearable health startups to expand their orthopedic portfolios.
2. IPO (5-7 Years): Scale to $100M+ annual revenue with global distribution + multiple product lines – eligible for NASDAQ/NYSE listing.
We’re excited to partner with investors who share our mission: to make knee health monitoring accessible, proactive, and personalized for everyone.
Next Steps
to Invest
1. Book a 1-on-1 Meeting at CES 2026 – Scan our booth QR code or use the link below to schedule a private demo of our product.
2. Request Our Full BP & Data Room – We’ll share detailed clinical results, pre-order contracts, and financial projections for qualified investors.
3. Reach Out Directly – Our Investor Relations lead is available 24/7 during CES to answer your questions.